Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Phase I trial to study the effectiveness of imatinib mesylate in treating patients who have advanced cancer and liver dysfunction
Epistemonikos ID: ce59f1f70953deae9b79953d1390665422bac189
First added on: May 03, 2024